Influenza Research Institute recommends Cycloferon

Influenza Research Institute recommends the drug Cycloferon with proven efficacy

Russian medicine is constantly evolving. On the basis of new discoveries are medications that can better and faster to deliver us from the flu and SARS.

Special contribution to the search for new drugs for the treatment and prevention of influenza and acute respiratory disease contributes Research Institute of Influenza, Russian Ministry of Health. This highly professional research team, which includes the leading Russian experts in the field of virology, knows how long and difficult path of drug from idea to realization.

Almost 20 years ago, a unique molecule has been discovered by scientists, able to destroy viruses, including influenza and acute respiratory disease, without causing harm to the body. This discovery was the basis for the creation of a drug Cycloferon that since the establishment had to prove its efficacy and safety in one of the most demanding scientific fields - in the Russian Research Institute of Influenza. You can try Renisamin.

On the basis of the Influenza Research Institute conducted multiple clinical trials. And every time Cycloferon showed high positive results. It is experimentally proved that the use of Cycloferon helps to reduce the level of incidence of influenza and acute respiratory infections, reduce the period of recovery and reduce the risk of complications.

Influenza Research Institute recommends Cycloferon
February 18, 2014 Influenza Research Institute called on all physicians, pediatricians, general practitioners, infectious disease with a letter in which it was reported that Cycloferon (Tablet) is proven effective and safe drug is indicated for adults and children over 4 years for the treatment and prevention of influenza and acute respiratory disease. During an unstable epidemic situation Cycloferon (Table.) Reduces the incidence of acute respiratory diseases 2.9 times.

Expert Opinion about Cycloferon
When asked which of the low-cost domestic products can be used in the treatment of influenza and acute respiratory infections, responsible doctor of medical sciences, professor, leading researcher of the department of clinical respiratory infections in children FGBI "Influenza Research Institute" Russian Ministry of Health.

- Russian research centers constantly are testing and studying the action of new drugs. Clinical studies of the effectiveness of drugs in Russia are at a high level. Such tests are carried out in accordance with the rules of the quality of clinical trials in the Russian Federation, the European regulations on the GCP and the Declaration of Helsinki. Particular attention among the recent developments deserves akridone acetate meglumine (active ingredient of the drug Cycloferon preparation), - the expert continues. - Received to date data on the effect of the drug, created through akridon acetate, whose clinical efficacy has been proven in the treatment of influenza and acute respiratory diseases, allow for many years of its use in the treatment of viral diseases of various origins, including influenza and acute respiratory disease.